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Abstract
● Strabismic amblyopia is characterized by a distorted 
spatial perception. In this condition, the neurofunctional 
disorder occurring during first years of life provoke several 
monocular and binocular anomalies such as crowding, 
deficits in the accommodative response, contrast sensitivity, 
and ocular motility abilities. The inhibition of the binocular 
function of the brain by the misaligned amblyopic eye 
induces a binocular imbalance leading to interocular 
suppression and the reduction or lack of stereoacuity. 
Passive treatments such as occlusion, optical and/or 
pharmacological penalization, and Bangerter foils has 
been demonstrated to be potentially useful treatments 
for strabismic amblyopia. Recent researches have proved 
new pharmacological options to improve and maintain 
visual acuity after occlusion treatment in strabismic 
amblyopia. Likewise, the active vision therapy, in the last 
years, is becoming a very relevant therapeutic option in 
combination with passive treatments, especially during and 
after monocular therapy, in the attempt of recovering the 
imbalanced binocular vision. 
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AMBLYOPIA: GENERAL DESCRIPTION
A mblyopia (lazy eye) is described as a limitation of the visual function of one or both eyes with no pathological 
cause. It is a disorder of spatial vision which cannot be 
improved by refractive correction[1]. Clinically, amblyopia can 
be defined as the presence in one or both eyes of a visual acuity 
of 6/12 or worse, with one or more lines of difference in visual 
acuity between eyes in unilateral amblyopia[2]. This condition 
is an alteration of the visual cortex function which is due to 
suppression and deprivation of one eye leading to unilateral 
visual deterioration[3]. 
The first binocular experience begins at birth and the 
development is almost complete at 24mo of age[4]. At this 
stage of life, any obstacle impeding the brain from receiving 
correctly a clear and similar image from each eye may lead 
to the development of amblyopia[4]. Likewise, the longer the 
duration of the abnormal visual experience, the higher the 
level of amblyopia is[5]. If the images from both eyes are not 
similar, the phenomenon of retinal rivalry appears, which is the 
capacity of the visual system to detect and discriminate those 
fusionable stimuli from those which are not. 
Amblyopia has been considered structurally monocular[6-8] and 
the correction of the abnormal visual input and penalisation 
of the “normal” input has been considered the mainstay of 
therapy for amblyopia[9]. The neural mechanisms of amblyopia 
are not completely understood even though they have been 
investigated with electrophysiological recordings in animal 
models and more recently with innovative neuroimaging 
techniques in humans[10]. New research is being developed 
on neuronal rivalry due to early functional imbalance[11] 
between both eyes in amblyopia and neural plasticity in adult 
patients[12].
Binocular vision is the sum of sensorial and motor balance in 
the first months of life. If there is any anatomical-physiological 
failure in this phase of development, a functional imbalance 
between both eyes is created. Binocular competition is what 
determines which eye is dominant. The information that the 
brain receives from each eye can be modified by different 
functional anomalies, leading to amblyopia. Depending on 
such functional anomalies, the following types of amblyopia 
can be defined.
Clinical management of strabismic amblyopia
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Anisometropic or refractive amblyopia: this sensorial alteration 
is produced by a refractive error and by a significant difference 
in the magnitude of such error between both eyes. In this latter 
case, the brain receives two projected images of different sizes. 
The greater the difference, the more difficult is the fusion of 
images from both eyes to create one single three-dimensional 
image. The most common refractive errors with a high 
amblyopiogenic value, from more to less effect, are hyperopia, 
astigmatism, and myopia.
Strabismic amblyopia: caused by the deviation in one of the 
eyes. In this case, the brain receives two different images with 
different spatial projection, one of them coming from the eye 
with the squint. This situation leads to a neuronal vulnerability 
as the brain cannot create a combination of images from both 
eyes to generate a stereoscopic vision.
Furthermore, both refractive and strabismic amblyopia can 
coexist in the same patient resulting in mixed anisometropic 
amblyopia, which is the combination of a refractive error and 
the misalignment of one eye. Another cause for amblyopia 
is the presence of a specific pathology inducing an abnormal 
entry of visual information due to corneal lesions, congenital 
cataracts and ptosis[13] at a young age, avoiding the generation 
of a normal binocular experience. Because of the above-
mentioned options, there is a dramatic loss of visual acuity in 
an apparently healthy eye and some other perceptual anomalies 
including deficits in contrast sensitivity and stereopsis[14].
Good anatomical and physiological balance of the eyes is 
not the only requirement for a functional binocular vision. 
A correct development of all the monocular functions is also 
necessary to transform the information coming from each one 
in a three-dimensional perception. The following monocular 
functions can be altered in strabismic, anisometropic or mixed 
amblyopia.  
Accommodative response: amblyopia does not only have a 
negative effect on visual acuity, but also creates an unequal 
accommodative response between the amblyopic and dominant 
eye. There is a marked limitation of the accommodative 
response in almost all the spatial frequency range due to an 
early abnormal visual experience associated with the presence 
of squint and/or anisometropia[15], with a prolonged effect on 
the sensory visual system[16]. 
Crowding: this phenomenon is more characteristic of strabismic 
amblyopia. This effect in the amblyopic eye is a simultaneous 
fixation originated around the fixation zone, the fovea. The 
effect is that there are multiple interferences in the images 
which result in an unclear image at the cortical level coming 
from the amblyopic eye. The critical distance for crowding 
increases with retinal eccentricity[17-18].
Contrast sensitivity: defined as the inverse of contrast threshold 
which is the least contrast necessary to perceive a stimulus. 
Strabismic amblyopia is characterized by a high spatial 
frequency disorder, whereas in anisometropic amblyopia 
the limitation in sensitivity is across the whole frequency 
range[19-22].
Ocular motility: the behaviour of ocular motility has been 
assumed to be another disorder of strabismic amblyopia[23]. 
Hand-eye coordination[24] is associated to a reduction in the 
ability of movement cortical control due to amblyopia[23]. 
Eccentric fixation has its origins in an increase in the saccade 
reaction time to starting a movement[24] and asymmetric 
saccades to tracking movements during reading. Defective 
spatial localization is also an important feature of strabismic 
amblyopia[25-26]. Amblyopia in general is associated with slower 
reading speed in school-age children[27].
The sensory rivalry in the visual cortex on the part of the 
dominant eye is an effect of an inhibitory activation of the 
visual information from the amblyopic eye. This cortical 
phenomenon which occurs in conditions of binocular 
vision has been catalogued throughout clinical history as 
“suppression”, “neutralisation”, “inhibition” or “exclusion”. 
The first author who developed this concept occurring in 
amblyopia was Javal. This phenomenon is a mechanism in 
the brain faced with different stimuli coming from both eyes 
during the development of binocular vision. According to 
this, a scotoma is developed to avoid diplopia and confusion. 
The suppression can be present in both types of amblyopia, 
anisometropic (the difference between images in size and 
contrast) and strabismic (the difference in spatial projection). 
One study performed an experiment to evaluate the degree 
of suppression in patients with strabismic, anisometropic and 
mixed amblyopia[28], measuring the degree of suppression in 42 
amblyopic patients. The results of this study demonstrated that 
a stronger suppression was associated with greater interocular 
difference in visual acuity and a weaker stereopsis. Patients 
with strabismus presented stronger interocular suppression[29-30] 
than anisometropic amblyopia[31]. 
Recently, the measurement of the suppression has been 
shown to have a prognostic value for occlusion therapy[28]. 
Considering the role of suppression in amblyopia, new 
therapeutic options such as the use of dichoptic tools[32] to 
measure and treat suppression leading to better monocular and 
binocular results have been developed. 
The main objective of this review is to widen the knowledge 
about strabismic amblyopia, analyzing the bases of the 
currently available clinical treatments. 
In summary, the following monocular clinical findings can be 
observed in strabismic amblyopia: reduces visual acuity 
(far or near distances) in amblyopic eye; reduced contrast 
sensitivity, mainly for high spatial frequencies; eccentric 
fixation; reduced accommodative response; crowding effect 
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due to unstable foveal fixation; reduces spatial localization; 
Anomalous oculomotor behaviour: slower saccadic 
movements.
Binocularly, the following conditions can be observed in 
strabismic amblyopia: interocular suppression due to active 
cortical inhibition from dominant eye in binocular vision 
conditions, anomalous retinal correspondence (ARC), and lack 
of stereopsis.
Epidemiology and Risk Factors  Strabismus develops in 
approximately 5% to 8% of the general population[33]. The 
visual cortical structure is generated during fetal development 
in the absence of external causes and without any light stimuli. 
There is a consensus in the literature that there is a significant 
hereditary component in the cause of strabismus[34]. In addition, 
strabismic amblyopia is present within the first year of life in 
a great part of cases[35]. Early diagnosis, strabismus surgery[36], 
and active and/or passive[37-38]. Adequate treatment selection 
are important factors to recover the binocular imbalance.
Bilateral and Unilateral Sensory Adaptation: Eccentric 
Fixation and Anomalous Sensorial Correspondence  The 
success of the treatment in amblyopia depends on a complete 
and early examination, analyzing sensory and motor factors 
that can affect the development of binocular vision[34-35]. Before 
six months old, the visual system is only monocular, and 
the fovea fixation is important to initiate a normal binocular 
vision. An image must be projected in the macular area called 
fovea. In addition, in the fovea, there is a higher density of 
cells called cones providing the maximum visual acuity[39]. The 
development of the fusion starts from the fovea maturation at 
around six months of life. In this period, if a sensorial and/or 
motor imbalance occurs due to different types of amblyopia, 
suppression will be active in the visual cortex[28]. In addition, 
there will be an anomalous binocular adaptation to connect the 
information coming from both eyes. 
Strabismus amblyopia is characterized by an imbalance of the 
sensorial and motor system. Differences between both eyes 
due to a squint during the first months of life can originate 
an eccentric fovea fixation and ARC[40], which is a binocular 
condition generated by the absence of a correct bifoveal fixation. 
Eccentric Fixation  Eccentric fixation is a monocular sensorial 
disorder associated with a unilateral and constant eye 
deviation, as happens in strabismic amblyopia[40]. This 
condition can be also present in non-strabismic cases, causing 
a drastic reduction of visual acuity and contrast sensitivity, as 
well as a loss of directional monocular capacity[39].   
The degree of eccentricity of fixation is defined as the distance 
where the fixation point is located with respect to the fovea in 
the non-dominant eye and can be nasal or temporal depending 
on the type of strabismus[41-42]. The fixation can be stable or 
unstable and the position of eccentric fixation is analysed 
under monocular conditions, with an ophthalmoscopy-
based observation technique called visuscopy[40]. It can be 
also measured with subjective techniques depending on the 
patient’s answer, such as the use of the Haidinger brush[43], 
which is only perceived by the fovea. Currently, new imaging 
objective methods have been developed to measure eccentric 
fixation such as the use of optical coherence tomography (OCT) 
systems[40,44] (Figure 1) and microperimeters[41]. The OCT 
allows a complete analyse of the macula area for pathology 
screening but also can be used to quantify fixation changes 
before and after amblyopic treatments[40]. Likewise, it has been 
demonstrated that the foveolar thickness in eyes with moderate 
to severe amblyopia is significantly greater than in the non-
amblyopic eye[42]. 
Occlusion, opaque contact lenses, vertical prisms, and pleoptic 
methods have been used for eccentric fixation treatment[45]. 
In order to weaken a stable eccentric fixation, occlusion in 
the amblyopic eye is employed. In this way, in the absence 
of light, the fixation becomes unstable and the dominant 
eye occlusion should be the following step of the treatment. 
Concerning pleoptics, its use started around the 1950s. 
Bangerter and Cüppers were the main authors who used them 
to treat eccentric fixation in amblyopia[46], being Bangerter 
the first clinician using the pleoptic methods (pleoptophor 
and cheiroscope)[47] and reporting his experience with them. 
Afterwards, Cüppers simplified and modified these methods 
for a more general use by clinicians including instruments, 
such as the visuscope, euthyscope, flickering light and the 
coordinator[48].
In strabismic amblyopia treatment, the most effective option 
for total or partial improvement in eccentric fixation was the 
combination of pleoptic methods with conventional occlusion 
(Table 1)[45,47-50]. In cases of a non-effective occlusion therapy, 
pleoptic and orthoptic techniques may lead to an improvement 
in patients with strabismic amblyopia and eccentric 
fixation[47,49]. Another application of Cüppers methods was the 
evaluation of the macular fixation reflex to early diagnosis in 
the prevention of amblyopia[51].
In summary, pleoptic methods (Bangerter and Cüppers) 
emerged as an early stimulation of foveal fixation in infants 
with strabismic amblyopia. Eccentric fixation is vulnerable 
and treatable by occlusion or passive treatment, but active 
treatment seems to be necessary to maintain central fixation in 
some cases[52]. Some forms of pleoptic and orthoptic treatment 
have been implemented and combined nowadays and defined 
as active visual therapy.  
Anomalous Sensorial Correspondence  Strabismic 
amblyopia is not only a monocular condition, it can also lead to 
a binocular disorder. Specifically, the dominant fovea originates 
a sensorial correspondence in the other eye without foveal 
Clinical management of strabismic amblyopia
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fixation to simulate a binocular vision. As foveal fixation is 
not possible in the strabismic eye, the visual directions of both 
eyes are not coincident, and an anomalous correspondence can 
be generated. This condition is called ARC. In other words, an 
anomalous binocular vision may be induced with some types 
of strabismus as some other sensorial binocular mechanisms 
including suppression, confusion or diplopia[53]. The degree 
of strabismus and the stability of fixation are critical factors 
influencing on this sensorial adaptation. 
When normal retinal correspondence (NRC) is present, 
bifoveal fixation exists after the correction of the deviation, 
with both eyes having the same point of monocular direction. 
In such case, the objective deviation measured by cover test 
or sinoptophore[54] coincides with the subjective deviation. 
However, if ARC is present, bifoveal fixation is not possible 
because monocular directions of both eyes are not the same, 
with the presence of a minimal angle or degree of strabismus, 
called microtropia[55] or microstrabismus, even after surgery 
Figure 1 Eccentric fixation characterized by OCT in a 12-year child with strabismic amblyopia in right eye.
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or prism treatment. It should be considered that ARC, central 
scotoma, reduced or absent stereopsis, amblyopia and eccentric 
fixation are considered special characteristics of microtropia[40]. 
Eccentric fixation is a failure of the monocular directional 
capacity whereas ARC is a binocular vision disorder leading to 
an anomalous correspondence between eyes. 
Concerning microtropia[54] or monofixation syndrome[55], 
there are some hypotheses about sensorial adaptations in this 
condition. Parks[56] concluded that small angle deviation and a 
binocular projection leading to a peripheral binocular condition 
are present in microtropia or monofixation syndrome. 
According to Lang in 1983[57], 1% of the general population 
has microstrabismus of less than 5 degrees. In addition, this 
author stated that microtropia may be primary constant, 
primary decompensating or secondary. Microtropia can be 
defined as with or without identity depending if the deviation 
can be detected or not with the cover test[58]. Some theories 
and potential etiologies have been described for microtropia, 
such as genetic default, suppression, insufficient correction of 
hyperopia, insufficient strabismus surgery or an imperfectly 
cured amblyopia[59]. 
The management of microtropia has been suggested to be 
based on treating anomalous correspondence with after-
images and on performing intensive postoperative orthoptic 
training as a solution for small residual deviations[58]. Diplopia 
and the impossibility of obtaining bifoveal fixation and full 
stereoacuity may be risks of microtropia treatment. However, a 
study performed by Houston et al[59] in 1993 contradicts these 
risks. This study showed the results of the treatment (mid-
time occlusion therapy and close work during patching) of 30 
patients with microtropia (eccentric fixation and ARC). These 
authors reported that 21 of these patients improved stereopsis 
to levels of 60-120s of arc or better. Another study evaluating 
the results of microtropia treatment with occlusion therapy was 
conducted by Cleary et al[58]. In this series, NRC, improvement 
of visual acuity to 6/5 and stereopsis to 30s of arc were 
observed after treatment in 7 patients[58]. Scientific evidence 
on the efficacy of orthoptic methods to treat microtropia in 
strabismic amblyopia has not been reported. 
Passive Treatment of Strabismic Amblyopia  Optical 
correction is the first step before the selection of the adequate 
therapy to treat the visual reduction in strabismic amblyopia. 
The relationship between accommodation and convergence 
must be considered in esotropia and amblyopia therapy. Infant 
refractive correction substantially reduces accommodative 
esotropia and amblyopia incidence, with no interference in 
the emmetropization process[60]. Correcting refractive errors in 
one or both eyes produces an equal accommodative response, 
as well as an improved and stable visual acuity in both eyes 
(Table 2)[61]. Therefore, the prescription of refractive correction 
should be considered as the sole initial treatment for children 
with strabismic or mixed amblyopia (Table 2)[62-64]. Improved 
visual acuity before initiating other types of treatments would 
presumably make occlusion or penalisation therapies less 
onerous, improving compliance and avoiding unnecessary 
patching[61-62,65]. Contact lenses, including opaque contact 
lenses for patching[66], and bifocal optical lenses are other 
alternatives of refractive correction in strabismic amblyopia.
Besides optical correction, controversy about the correct 
treatment of strabismic amblyopia remains despite the 
Table 1 Summary of the main clinical findings of the use of pleoptics in strabismic amblyopia with eccentric fixation
Authors Main objectives Year Patients Treatment Main results
Vonnoorden and 
Lipsius[48]
To analyse the pleoptic 
therapy results in strabismic 
amblyopia
1964 58 strabismic 
amblyopia
Direct or inverse patching
Cüppers and Bangerter 
pleoptics
Pleoptics did not produce a significative 
improvement of visual acuity
VerLee & Iacobucci[45] To evaluate the results 
(visual acuity and central 
fixation) of treatment with 
Cüppers pleoptic method and 
occlusion 
1967 100 strabismic 
amblyopia
50 patients with Cüppers
50 patients with full-time 
occlusion (dominant eye)
Occlusion was better than pleoptic therapy 
in all age range
Schmidt & Stapp[49] To compare the results of 
occlusion and euthyscope 
together with occlusion




Group with euthyscope 
followed by occlusion
No significant difference was apparent after 
comparison of both forms of treatment
Four of 6 patients with occlusion (without 
success) therapy improved with pleoptics 
followed by further occlusion
Jablonski &
Tomlinson[47]
To evaluate pleoptic and 
orthoptic methods after no 
effective occlusion treatment
1979 64 patients (4-17y) 
with amblyopia 
(20/30-20/100)
Pleoptic+orthoptic After therapy, 64 patients achieved 20/30 
or better
25 patients achieved stereopsis
After therapy, visual acuity was followed 
in 27 patients and 88% maintained 20/30 
or better of visual acuity (fusion or ARC)
Bogdan[50] To analyse the results of 
pleoptic together with 
occlusion 
1992 161 strabismic 
amblyopia
Active treatment with 
amblyophor and occlusion
A total cure was found in 38%, 
improvement in 46% and fail in 16% of 
cases
ARC: Anomalous retinal correspondence.
Clinical management of strabismic amblyopia
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available scientific evidence. The negative impact on school-
aged children, the true fulfilment of occlusion time and the 
new options for treatment in adult patients have led to new 
forms of amblyopia management. Occlusion, pharmacological 
and/or optical penalization, and Bangerter foils are the classical 
methods for amblyopia treatment. New pharmacological 
medications, such as Levodopa or Carbidopa, perceptual 
learning, dichoptic training, the use of virtual reality and 
transcranial stimulation are new options under investigation 
currently.
Occlusion  Direct occlusion (patching on the dominant eye) 
has been considered as a standard treatment in all types 
of amblyopia, including strabismic amblyopia. Full-time 
occlusion was the overriding treatment during many years as 
amblyopia was considered a monocular problem. However, 
the degree of residual binocularity and interocular suppression 
have been shown to predict the monocular visual acuity, 
being a significant etiological mechanism of vision loss in 
amblyopia[67]. Several studies have confirmed that the average 
improvement in visual acuity is better in mixed anisometropic 
amblyopia than in strabismic amblyopia[67-71]. 
Another concern after cessation of pathing is the recurrence 
of amblyopia, with approximately one fourth of successfully 
treated amblyopic children experiencing a recurrence within 
the first year after treatment[72]. The risk of recurrence is greater 
when patching is stopped abruptly[73-74] and microstrabismus is 
present[75].
Less intensive occlusion treatments can be successful in 
strabismic amblyopia (Table 3)[75-80]. The accommodation 
stimulation during occlusion time has been proved to improve 
visual acuity in strabismic amblyopia (Table 3)[81-87]. It 
should be considered that the accommodative response is 
mainly mediated by the level of focusing at fovea. Therefore, 
the performance of near vision activities as well as direct 
accommodative training are simultaneously generating some 
type of fixation training, although in some cases additional 
active treatment with pleoptic methods may be necessary. 
Then, occlusion therapy combined with near activities is not 
only promoting an improvement of visual acuity but also in the 
accommodative range and even in contrast sensitivity, which 
are normally deficient in the strabismic eye. 
Finally, the efficacy of occlusion therapy has been shown 
to be not so dependent on patient’s age. Indeed, strabismic 
amblyopia has been demonstrated that can be recovered after 
6y[66]. According to the peer-reviewed literature revised on 
patching in strabismic amblyopia, 2 to 6h of occlusion seems 
to be the most adequate option in moderate amblyopia. The 
combination of 6h of occlusion and near activities or vision 
therapy is the most optimum protocol to follow in severe 
amblyopia.  
Drug Therapy
Atropine  Atropine is one option of passive treatment called 
pharmacological penalization[88]. It is administered topically in 
the dominant eye, manipulating the refractive status of the eye 
and a thereby affecting alignment, focus and amblyopia[89]. The 
atropine effectiveness alone or together with other methods has 
been evaluated as a passive therapy of treatment in strabismic 
amblyopia patients (Table 4)[90-99]. 
As occlusion treatment, the atropine protocol has been 
modified and reduced but trying to maintain the same 
effectiveness. “Weekend atropine” has been shown to be as 
effective as daily atropine[90] and patching in children with 
both moderate and severe amblyopia as well as specifically in 
strabismic amblyopia[90-93]. Furthermore, the atropine and the 
occlusion treatment have similar rates of reverse amblyopia 
such as daily atropine vs full-time occlusion and improvement 
Table 2 Summary of the main clinical findings of optical correction that can be observed in strabismic amblyopia according to 
scientific peer-reviewed literature
Authors Type of study Main objectives Year Patients Treatment Main results
Stewart et al[62] Retrospective 
study
To describe the visual 
response to spectacle 
correction (“refractive 
adaptation”)
2004 Strabismic (n=16) 






Average of visual acuity improvement 
in the 3 types of amblyopia (from 
0.67±0.38 to 0.43±0.37 logMAR)
Regardless of amblyopia type, 
refractive adaptation should be a first 
state before any therapy
Cotter et al[64] P r o s p e c t i v e , 
interventional 
case series
To report data on the 
response of previously 
untreated strabismic 
amblyopia to spectacle 
correction




Visual acuity improved a mean of 
2.2±1.8 lines
2 lines or more in the amblyopic eye 
in 9 patients
3 patients had only interocular 
difference ≤1 line
Cotter et al[63] P r o s p e c t i v e , 
m u l t i c e n t r e , 
cohort study
To determine visual acuity 
improvement with optical 
adaptation in children with 
strabismic and combined 
strabismic-anisometropic
2012 146 children with 
strabismic (n=52) 




Visual acuity improved a mean of 2.6 
lines
Resolution of amblyopia occurred in 
32%
More improvement of visual acuity in 
strabismic amblyopia (strabismic 3.2 
vs mixed 2.3)
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in ocular alignment and binocularity after treatment in 
strabismic amblyopia[94-95].
The weekend atropine protocol combined with full optical 
correction in severe strabismic amblyopia seems to be 
according to the scientific literature a satisfactory option. 
However, in moderate amblyopia, the visual improvement 
achieved with daily atropine or weekend atropine does not 
seem to differ significantly. 
Levodopa/Carbidopa  Levodopa/Carbidopa is a pharmacological 
combination which is used for the treatment of Parkinson’s 
disease as well as for the treatment of tremors (shaking), 
stiffness and slow movements caused by lack of dopamine. 
Levodopa is a central nervous system agent, acting as a 
precursor amino-acid of dopamine in the brain. Carbidopa 
is a decarboxylase inhibitor medication[100]. Experimental 
studies with animals have shown that visual deprivation was 
linked to retinal dopamine concentration[101]. In humans, the 
use of levodopa/carbidopa has been shown to affect contrast 
sensitivity and binocular suppression in amblyopia[88]. This 
pharmacological combination has been proved in humans 
with amblyopia, being used in most of cases in strabismic 
amblyopia (Table 5)[102-106]. Several reports used levodopa/
carbidopa together with occlusion treatment, suggesting that 
levodopa may add to the effect of occlusion. Furthermore, 
levodopa/carbidopa are effective in severe amblyopia 
and bilateral amblyopia, promoting the improvement and 
maintenance of visual acuity after treatment[103-105]. Therefore, 
the use of levodopa is an effective and safe option for the 
Table 3 Summary of the main clinical findings of occlusion therapy that can be observed in strabismic amblyopia according to 
scientific peer-reviewed literature







To compare visual outcome 
of full-time vs 6h patching 
daily combined with near 
activities





vs 6h (each combined 
with at least 1h of near 
activities)
Average visual improvement 
4.7 lines full-time occlusion vs 






To compare 2h vs 6h of 
daily occlusion combined 
with near activities  




2h daily occlusion + near 
activities vs 6h daily 
occlusion + near activities
Average visual improvement 





To investigate the 
compliance with patching 
therapy with occlusion dose 
monitors
2005 52 strabismic or mixed 
amblyopia patients 
(6/12-6/48 Snellen)
No patching vs 3h 
occlusion vs 6h occlusion 





Compliance rate: 57.5% 3h vs 
41.2% 6h
Mean visual improvement 
0.24 in no pathing, 0.29 in 3h 







To compare 2h of daily 
patching combined with 1h 
of near activities vs only 
optical correction treatment 
2006 108 strabismic or mixed 
amblyopia patients 
(20/40 to 20/400) 3 to 7 
years old
Daily occlusion for 
2h+near activities for 1h
vs control group: optical 
correction
The average improvement was 
1.1 lines in the patching group 
and 0.5 lines in control group
Best optical correction, 2h of 
occlusion and near activities 






To evaluate the 
improvement of visual 
acuity with 2h of occlusion 
plus near activities vs 2h 
occlusion plus distance 
activities





Group 1: 2h of 
patching+near activities 
vs Group 2: 2h of 
patching+distance 
activities
Average visual improvement 
in each group: 2.6 lines with 







To compare the efficacy 
of part-time vs full-time 
occlusion
2008 100 strabismic (n=25), 









Severe amblyopia (vision 
20/100 or worse): 6h of full-
time occlusion significantly 




Prospective study To evaluate the outcome of 
part-time occlusion therapy 
with or without near 
activities
2012 130 strabismic and/
or anisometropic 
amblyopia patients
Daily part-time occlusion 
(65 with 3h+near 
activities/65 without)
Average improvement
of 6.7±2.37-line logMAR (near 




Randomized trial To compare visual acuity, 
binocular function and 
refractive errors with 
alternate-day patching for 
8h or more and patching for 
≥8h (6d/wk)




Group 1: alternate-day 
patching for ≥8h
Group 2: patching for 
≥8h (6d/wk)
Final median visual acuity 
group 1 (0.0 logMAR) vs group 
2 (0.1 logMAR) 
Binocular function improved 
with both treatments
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treatment of amblyopia and may be considered as a first-line 
treatment in amblyopia[107].
Serotonin receptor inhibitor fluoxetine/catecholamine 
modulator citicoline/acetylcholinesterase inhibitor 
donezepil  These substances have been suggested as potential 
treatment options in amblyopia, which can be considered a 
developmental brain disorder leading to vision loss due to 
asymmetric or inadequate visual stimulation early in life[108]. 
Citicoline is used for Alzheimer’s disease and other types 
of dementia, head trauma, cerebrovascular disease such as 
stroke, age-related memory loss, Parkinson’s disease, attention 
deficit-hyperactive disorder (ADHD), and glaucoma[108]. 
Donepezil is used for the symptomatic treatment of mild 
and moderate Alzheimer’s disease[108]. The fluoxetine is a 
widely prescribed medication for treatment of depression[109], 
with some neurological clinical reports demonstrating 
Table 4 Summary of the main clinical findings of atropine penalization that can be observed in strabismic amblyopia according to 
scientific peer-reviewed literature





To evaluate the effect of 
atropine
1991 189 strabismic 
amblyopia patients






To compare the 
visual outcome and 
binocularity of occlusion 
vs penalization treatment
1997 192 strabismic 
amblyopia patients





No significant difference was found in 
the multivariate analyses controlling for 






To evaluate the 
monocular and binocular 
outcome (with three 
types of penalization)







Reduction of amblyopia (1.7-2.7 
logMAR lines)
DA, OP, WA produce a statically 






To evaluate the visual 
acuity of OP and AP 
after occlusion therapy 








Improvement with optical COAT 
(20/113 to 20/37)
22 patients recommenced occlusion 
after COAT







To compare daily to 
weekend atropine





Amblyopia 20/40 to 
20/80
Visual improvement in each group 2.3 
lines






To evaluate the change 
in alignment after 
amblyopia treatment 
(atropine vs patching)







161 (45%) achieved ortho: after 2y 
strabismus was present in 18% pathing 
vs 16% atropine
91 (25%) presented microtropia (1-8 
prism diopter): after 2y worsening of 
deviation 13 % pathing vs 15% atropine
105 (29%) had heterotropia (>8 prism 
diopter): after 2y 13% patching vs 16% 






To compare visual acuity 
and stereoacuity with AP 
and OP






Visual acuity improvement (AP 3.4 vs 
OP 1.8 logMAR lines)
Interocular difference improvement
AP 2.8 vs OP 1.3 logMAR lines








To determine the 
effectiveness of weekend 
atropine for severe 
amblyopia
2009 100 patients with 
severe amblyopia 
(20/125 to 20/400) due 
to strabismus and/or 
anisometropia
Group 1 (60 children 
3-6y): A-AW+plano lens 
vs B-AW+full optical 
correction
Group 2 (40 children 
7-12y): C-AW vs D-2 
daily occlusion
Group 1: average improvement 4.5 
lines B vs 5.1 lines A
Group 2: average improvement 1.5 





To evaluate the 
effectiveness of 
augmenting the effect of 
atropine by changing the 
lens over the fellow eye 
to plano in children with 
residual amblyopia
2015 73 patients (3 to <8y) 
with residual amblyopia 
(20/32 to 20/160)
WA vs DA plus plano 
lens
Average improvement: DA 1.1 lines vs 
WA 0.6 lines
OP: Optical penalization; AP: Atropine penalization; WA: Atropine weekend; DA: Atropine daily; COAT: Correction and atropine 
penalization treatment.
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that also restores plasticity in the adult visual cortex[109-110]. 
Fluoxetine can reinstate early-life critical period-like neuronal 
plasticity and has been used to recover functional vision in 
adult rats with amblyopia[111]. Currently, there is no doubt 
about the possibility of treatment of amblyopia in adult 
patients as neuronal plasticity is still present. However, these 
pharmacological therapies have shown limited efficacy in 
adult patients with amblyopia[112]. These studies point toward 
the intracortical inhibitory transmission as a crucial brake for 
therapeutic rehabilitation and recovery from amblyopia in 
the adult brain[112]. Nevertheless, more research is still needed 
to evaluate the use of these new drugs specifically only in 
strabismic amblyopia and to check for possible adverse effects 
after treatment.
Penalization Therapy
Optical penalization  The main objective of optical penalization 
is the change the focus of the image of the dominant eye 
by means of optical overcorrection. As atropine, optical 
penalization has a high acceptability, and has been used 
alone as an alternative for treating amblyopia or for its 
maintenance[113]. In addition, optical penalization has been also 
used as a maintenance treatment after occlusion treatment[99,113], 
and even to the improve the motor instability in strabismic 
patients. However, the minimal refractive penalization required 
for an optical treatment is not clear and defined, ranging in 
studies from +3.00 to +1.25 D[114]. 
A report with 163 strabismic amblyopic patients evaluated 
the monocular and binocular outcome with daily atropine, 
optical penalization and weekend atropine. The three types 
of penalization produced a statistically significant reduction 
in amblyopia (from 1.7 to 2.7 logMAR lines)[96]. In addition, 
the effectiveness of optical penalization and atropine was 
evaluated in 166 strabismic or anisometropic patients. A similar 
improvement of visual acuity with both types of penalization 
was found: 77% of patients with optical penalization and 76% 
of patients with atropine[115].
Bangerter foils  Another type of penalization treatment 
is the use of Bangerter foils (Ryser Optik AG, St. Gallen, 
Switzerland) or neutral density filters[116]. Its use began at the 
end of the 20th century as an alternative to measure interocular 
suppression scotoma in amblyopic patients[117]. The main 
objective of Bangerter foils is to reduce the contrast sensitivity 
and luminance in the non-amblyopic eye in order to avoid 
interocular suppression and to improve binocular balance in 
amblyopia[118].
A significant improvement at 3mo of treatment was registered 
in 30 children with strabismic amblyopia[119]. Furthermore, the 
reduction of interocular differences in strabismic amblyopia 
can improve the development of motor fusion, as has been 
reported in a study including 46 strabismic amblyopic patients. 
Specifically, 61% of patients developed motor fusion that was 
maintained at 13.3mo after treatment[120]. Therefore, Bangerter 
foils may be an alternative after monocular treatment or 
primary option in strabismic amblyopia[121] in order to reduce 
Table 5 Summary of the main clinical findings of levodopa/carbidopa treatment that can be observed in strabismic amblyopia 
according to scientific peer-reviewed literature







Efficacy and tolerance of 
a levodopa in normal and 
strabismic amblyopia. 




Levodopa (one single 
administration)
Levodopa induces short-term 
changes on contrast sensitivity 
(increase) and fixation point 









Efficacy and tolerance 
of a levodopa/carbidopa 
together with occlusion








0.51 mg/kg per day is well tolerated 
and produces a clinical and 
statistically significant short-term 






To evaluate the role of 
levodopa/carbidopa in the 
treatment of strabismic 
amblyopia





(0.50 mg+1.25 mg/kg)+ 
full-time occlusion
Improvement and maintenance of 
visual acuity in 100% of children <8 
years old and 60% of children >8 
years old
Rashad[104] Prospective study To compare a weight-
adjusted dose of carbidopa- 
levodopa




LC (n=28) vs O (n=35) LC>O (42.5% vs 30%) in adult 
patients
LC>O (34.3% vs 22%) in severe 
amblyopia
Levodopa may add to the effect of 
occlusion in severe amblyopia and 
bilateral amblyopia




Efficacy and tolerance of 
levodopa/carbidopa 









Levodopa/carbidopa can be used 
together with conventional occlusion 
therapy in amblyopia particularly in 
older children and severe cases of 
amblyopia, being well tolerated
LC: Levodopa/carbidopa+occlusion; O: Occlusion only.
Clinical management of strabismic amblyopia
1141
Int J Ophthalmol,    Vol. 13,    No. 7,  Jul.18,  2020         www.ijo.cn
Tel: 8629-82245172     8629-82210956      Email: ijopress@163.com
interocular suppression and to improve fusion development[122]. 
According to the literature, this option seems to be an 
alternative in moderate cases of strabismic amblyopia, but not 
in severe cases as an important reduction of visual quality is 
required in the dominant eye and children try to avoid the filter 
looking over the glasses. Indeed, a significant correlation of 
the visual acuity achieved at 3mo of treatment with Bangerter 
foils in strabismic amblyopia with the baseline visual acuity 
difference among eyes has been reported[119]. It should be 
considered that the selection of the filter to prescribe is based 
on the criteria defined by Odell et al, which were to achieve a 
reduction of visual acuity in the non-amblyopic eye capable of 
inverting the ocular dominance[119]. 
Other Treatments
Transcranial magnetic stimulation  Transcranial direct 
stimulation is a new experimental treatment of amblyopia. 
Recent studies show that repetitive transcranial magnetic 
stimulation (rTMS) of the visual cortex can temporarily 
improve contrast sensitivity in the amblyopic eye, including 
the experimental studies conducted to this date some 
strabismic cases[123-125]. A recent report with rats have shown 
that transcranial direct-current stimulation (tDCS) treatment 
improves the visual acuity of the amblyopic eye, with a 
significant increase of parvoalbumin-positive cells in three 
areas of the visual cortex (V1M, V1B and V2L), both in 
the stimulated hemisphere but also in the non-stimulated 
hemisphere[126]. More research is still needed before the 
clinical application of this treatment in order to define the 
best protocols to optimize the outcome and to minimize the 
potential side effects.
Active treatment of strabismic amblyopia  Binocular 
balance is the step following monocular stimulation. The active 
treatment to recover binocular imbalance in a crucial step for 
a complete rehabilitation of amblyopia. The active therapy 
adds visual exercises and/or self-monitoring systems such as 
biofeedback that combined with passive treatment may lead to 
a successful management of strabismic patients[127].
Strabismic amblyopia is characterized by interocular difference 
due to central suppression. The dichoptic training is a tool to 
monitor changes in interocular differences and suppression 
occurring in amblyopia[128]. Individuals with strabismic 
amblyopia have a very low probability of improvement with 
only monocular training, with potentially better outcomes 
using dichoptic training, and even better with direct stereo 
training[129]. Recently, it has been shown that amblyopes 
possess binocular cortical mechanisms for both threshold and 
supra threshold stimuli[130-131]. One critical factor is that active 
vision therapy under binocular conditions should be conducted 
after ensuring that bifoveal fixation is present. In strabismic 
amblyopia, this can be achieved with a previous compensation 
of the deviation with lenses, prisms or surgery. 
Visual training based on perceptual learning has been shown 
to be effective in children and adults with anisometropic 
amblyopia[132-134]. This new method of amblyopia treatment 
together with occlusion has evidenced that may significantly 
speed up the time of recovery in children with amblyopia[135]. 
In addition, there is a significant transfer of learning from the 
amblyopic to the dominant eye during perceptual learning 
treatment[136]. However, to this date, there is no study evaluating 
the results of perceptual learning specifically in strabismic 
amblyopia. In most of studies, only a minimal portion of 
patients enrolled in the study had strabismic amblyopia and 
therefore it is difficult to extract specific conclusions about 
the use of perceptual learning in this condition[137-138]. It is 
curious that the lowest visual improvements that has been 
reported with perceptual learning were reported in those series 
including a significant proportion of strabismic patients[137-138]. 
Possibly, the use of visual training with perceptual learning 
should be combined with patching in this type of patients, but 
this is something that should be addressed in future studies. 
Concerning dichoptic training, it is critical the presence of 
bifoveal fixation to initiate the treatment (prism, surgery) as 
well as the presence of a tolerable interocular difference in 
visual acuity (no more than 3 lines of difference)[139]. For this 
reason, in some cases, perceptual learning, dichoptic training 
and even patching are combined. Most part of the research on 
dichoptic training is related to anisometropic amblyopia[131-133]. 
Only a limited number of studies has included strabismic 
amblyopic patients in their samples and therefore it is difficult 
to extract consistent conclusions of this type of treatment in 
strabismic amblyopia[140]. All these researches suggest that 
dichoptic training may be considered as a phase of the visual 
training in strabismic amblyopia once the bifoveal fixation is 
restored. More studies are still necessary to confirm this issue. 
Finally, an incipient evidence of the use of virtual reality in 
anisometropic amblyopia has been published, showing the 
capability of this type of training of improving the visual acuity 
and promoting stereopsis[141]. However, there is no evidence 
to this date of the use of this type of therapy in strabismic 
amblyopia.
Treatment failure  In some cases, the visual recovery 
achieved following the protocols established by the peer-
reviewed literature is limited in strabismic amblyopia, even 
with a complete failure of the treatment. A potential cause for 
this unsuccessful outcome may be the presence of sensory 
adaptations, such as retinal correspondence anomaly or 
eccentric or unstable fixation, that have not been detected 
in the baseline examination and have limited the visual 
rehabilitation. In such cases, a complete visual sensory 
examination is recommended to discard this potential source of 
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limitation of the visual outcome. Kirandi et al[142] confirmed in 
a previous study that a large interocular difference in the best-
corrected visual acuity was a risk factor for both functional 
and relative failure of amblyopia treatment. This suggests that 
passive and active treatment should be combined in this type 
of cases to achieve a more successful visual acuity recovery, 
but this should be confirmed in future studies. Likewise, Seol 
et al[143] concluded in another study that intermittent atropine 
penalization for 4mo could improve best corrected visual 
acuity in children with amblyopia for whom patch therapy 
has failed. Specifically, these authors stated that atropine 
penalization could be especially effective in younger children 
and those with poor best corrected visual acuity at the start of 
atropine penalization in the amblyopic eye[143].
CONCLUSIONS
Strabismic amblyopia is a type of amblyopia with some 
clinical peculiarities that differentiate it from anisometropic 
amblyopia in terms of clinical signs, treatment planning and 
visual prognosis. Refractive correction is a mandatory first step 
before initiating and planning any treatment in this condition. 
Research studies have confirmed that strabismic amblyopia 
can be treated successfully with part-time occlusion and 
weekend atropine, obtaining a similar effectiveness in even 
severe amblyopia. The use of 6-hour occlusion combined with 
the performance of near vision activities seems to be the best 
option of occlusion treatment in this amblyopic condition. 
Concerning the use of optical penalization and Bangerter foils, 
more information on the real effectiveness of these treatment 
options and the level of penalization required with each one is 
still needed to define general and consistent recommendations 
about their use in strabismic amblyopia. An alternative 
effective option of treatment in strabismic amblyopia is the use 
of levodopa/carbidopa combined with occlusion, although the 
potential long-term effects of this medication is still unknown. 
As far as other drug therapies, more research is needed 
to evaluate the use of these new drugs only in strabismic 
amblyopia and to check for possible adverse effects after 
treatment. 
Concerning active vision therapy, minimal scientific evidence 
has been still provided in strabismic amblyopia, especially in 
the area of perceptual learning training, in spite of the more 
consistent evidence reported in anisometropic amblyopia. 
Future studies should be conducted to assess the potential 
greater benefit of combining passive methods with the 
recent methods of active vision therapy. Finally, transcranial 
magnetic stimulation is another potential option of treatment in 
strabismic amblyopia, but the evidence about its efficiency and 
safety is still very poor.
Finally, it should be remarked the relevant limitations of 
studies analysing the outcomes of strabismic amblyopia 
treatment. First, the samples evaluated are normally small 
which is a consequence of the relatively limited prevalence 
of strabismic amblyopia. According to this, more multicentre 
studies should be conducted to overcome this limitation. One 
of the most controversial issues on amblyopia research is the 
combination of strabismic and anisometropic amblyopes, 
considering that the behaviour and prognosis of these two 
conditions are different. More studies evaluating specifically 
the outcomes of treatment of strabismic amblyopia are needed 
in order to provide more specific treatment criteria for this 
sample of patients. Likewise, comparative clinical trials 
evaluating outcomes of a specific treatment but considering 
a sample of strabismic amblyopes exclusively are lack and 
would be necessary in the future to understand better this 
condition and provide more realistic data to patients about the 
prognosis of such condition.
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